Peptide Functionalization of Emulsion-Based Nanocarrier to Improve Uptake across Blood-Brain Barrier.
Alberta De CapuaRaffaele VecchioneCinzia SgambatoMarco ChinoElena LagrecaAngelina LombardiPaolo Antonio NettiPublished in: Pharmaceutics (2024)
New strategies for enhancing drug delivery to the blood-brain barrier (BBB) represent a major challenge in treating cerebral diseases. Nanoemulsion-based nanocarriers represent an ideal candidate to improve drug delivery thanks to their versatility in functionalization and cargo protection. In this work, a paclitaxel-loaded nano-emulsion has been firstly functionalized and stabilized with two layers constituted of chitosan and hyaluronic acid, and, secondly, the latter has been conjugated to the CRT peptide. CRT is a bioactive peptide that selectively recognizes bEnd.3 cells, a model of the BBB, thanks to its interactions with transferrin (Tf) and its receptor (TfR). Cytotoxic results showed a 41.5% higher uptake of CRT functionalized nano-emulsion than the negative control, demonstrating the ability of this novel tool to be accumulated in brain endothelium tissue. Based upon these results, our approach can be fully generalizable to the design of multifunctional nanocarriers for delivery of therapeutic agents to the central nervous systems.
Keyphrases
- drug delivery
- blood brain barrier
- cerebral ischemia
- hyaluronic acid
- cancer therapy
- drug release
- cardiac resynchronization therapy
- induced apoptosis
- quantum dots
- white matter
- heart failure
- cell cycle arrest
- photodynamic therapy
- resting state
- molecularly imprinted
- functional connectivity
- cell proliferation
- multiple sclerosis
- signaling pathway
- binding protein